187 related articles for article (PubMed ID: 34727750)
1. DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis.
Sun R; Yang L; Wang Y; Zhang Y; Ke J; Zhao D
J Int Med Res; 2021 Nov; 49(11):3000605211053722. PubMed ID: 34727750
[TBL] [Abstract][Full Text] [Related]
2. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
Dong W; Du D; Huang H
Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of DNAJB11 in epithelial ovarian cancer].
Guorong Y; Yunfeng FU; Yanli LI; Caiyun Z; Weiguo LV
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 46(2):173-178. PubMed ID: 28752709
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Pan Y; Wu L; He S; Wu J; Wang T; Zang H
Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
[TBL] [Abstract][Full Text] [Related]
6. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
7. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
Front Immunol; 2022; 13():964891. PubMed ID: 36059514
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Prognostic 3-Gene Risk Prediction Model for Thyroid Cancer.
Zhao H; Zhang S; Shao S; Fang H
Front Endocrinol (Lausanne); 2020; 11():510. PubMed ID: 32849296
[No Abstract] [Full Text] [Related]
10. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.
Fei H; Han X; Wang Y; Li S
Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551
[TBL] [Abstract][Full Text] [Related]
11. NKD2 is correlated with the occurrence, progression and prognosis of thyroid carcinoma.
Gao Y; Wang Y; Guo R
Eur J Med Res; 2022 Nov; 27(1):235. PubMed ID: 36348408
[TBL] [Abstract][Full Text] [Related]
12. TTN mutations predict a poor prognosis in patients with thyroid cancer.
Han X; Chen J; Wang J; Xu J; Liu Y
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive bioinformatics analysis unveils THEMIS2 as a carcinogenic indicator related to immune infiltration and prognosis of thyroid cancer.
Liu JF; Zou B; Xiang C; Yan HC
Sci Rep; 2024 Apr; 14(1):8156. PubMed ID: 38589421
[TBL] [Abstract][Full Text] [Related]
14. High expression of IL4I1 is correlated with poor prognosis and immune infiltration in thyroid cancer.
Zhu L; Wang J; Hu J
BMC Endocr Disord; 2023 Jul; 23(1):148. PubMed ID: 37434155
[TBL] [Abstract][Full Text] [Related]
15. The Identification of Three Key Genes Related to Stemness in Thyroid Carcinoma through Comprehensive Analysis.
Zhang T; Yan C; Ye Z; Yin X; Jiang TA
Comb Chem High Throughput Screen; 2021; 24(3):423-432. PubMed ID: 32767928
[TBL] [Abstract][Full Text] [Related]
16. Prediction Biomarkers Associated with Lymph Node Metastasis and Prognosis were Identified in Papillary Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Gan S; Ye R; Ha Y; Xiong Y; Li R; Di X; Zou Z; Sun Y; Zhang Z
Comb Chem High Throughput Screen; 2021; 24(9):1395-1409. PubMed ID: 33155892
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of Mitochondrial Transcription Termination Factor 3 in Thyroid Carcinoma.
Sun MT; Zhao HY; Ruan HJ; Yu LH; Guan ML; Fan JJ; Feng CZ; Lou YY
Genet Test Mol Biomarkers; 2023 Dec; 27(12):362-369. PubMed ID: 38156906
[No Abstract] [Full Text] [Related]
18. Construction and Evaluation of a Tumor Mutation Burden-Related Prognostic Signature for Thyroid Carcinoma.
Lu H; Liu Q; Chang Q; Du J; Zhang C; Chang W; Guo X; Hu Y; Liu S; Tang G; Chen C
Comput Math Methods Med; 2021; 2021():1435827. PubMed ID: 34697553
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics identify the role of chordin-like 1 in thyroid cancer.
Yu JW; Pang R; Liu B; Zhang L; Zhang JW
Medicine (Baltimore); 2023 Feb; 102(5):e32778. PubMed ID: 36749222
[TBL] [Abstract][Full Text] [Related]
20. Identification of Key Pathways and Genes Downstream of Insulin-Like Growth Factor 1 in Thyroid Carcinoma.
Wang J; Wu L; Lu W; Zhang H; Wu Y
Genet Test Mol Biomarkers; 2022 Nov; 26(11):522-531. PubMed ID: 36440844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
